Cargando…

Prioritization of family member sequencing for the detection of rare variants

BACKGROUND: The advent of affordable sequencing has enabled researchers to discover many variants contributing to disease, including rare variants. There are methods for determining the most informative individuals for sequencing, but the application of these methods is more complex when working wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sippy, Rachel, Kolesar, Jill M, Darst, Burcu F, Engelman, Corinne D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133500/
https://www.ncbi.nlm.nih.gov/pubmed/27980641
http://dx.doi.org/10.1186/s12919-016-0035-8
_version_ 1782471275307859968
author Sippy, Rachel
Kolesar, Jill M
Darst, Burcu F
Engelman, Corinne D
author_facet Sippy, Rachel
Kolesar, Jill M
Darst, Burcu F
Engelman, Corinne D
author_sort Sippy, Rachel
collection PubMed
description BACKGROUND: The advent of affordable sequencing has enabled researchers to discover many variants contributing to disease, including rare variants. There are methods for determining the most informative individuals for sequencing, but the application of these methods is more complex when working with families. Sets of large families can be beneficial in finding rare variants, but it may be unfeasible to sequence all members of these family sets. METHODS: Using simulated data from the Genetic Analysis Workshop 19, we apply multiple regression to identify cases and controls. To find the best controls for each case, we used kinship coefficients to match within families. Selected cases and controls were analyzed for rare variants, collapsed by gene, associated with hypertension using the family-based rare variant association test (FARVAT). RESULTS: The gene with the strongest simulated effect, MAP4, did not meet the Bonferroni corrected significance threshold. However, analysis of cases and controls using our selection method substantially improved the significance of MAP4, despite the reduction in sample size. CONCLUSIONS: Taking the additional steps to select the optimal cases and controls from large family data sets can help ensure that only informative individuals are included in analysis and may improve the ability to detect rare variants.
format Online
Article
Text
id pubmed-5133500
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51335002016-12-15 Prioritization of family member sequencing for the detection of rare variants Sippy, Rachel Kolesar, Jill M Darst, Burcu F Engelman, Corinne D BMC Proc Proceedings BACKGROUND: The advent of affordable sequencing has enabled researchers to discover many variants contributing to disease, including rare variants. There are methods for determining the most informative individuals for sequencing, but the application of these methods is more complex when working with families. Sets of large families can be beneficial in finding rare variants, but it may be unfeasible to sequence all members of these family sets. METHODS: Using simulated data from the Genetic Analysis Workshop 19, we apply multiple regression to identify cases and controls. To find the best controls for each case, we used kinship coefficients to match within families. Selected cases and controls were analyzed for rare variants, collapsed by gene, associated with hypertension using the family-based rare variant association test (FARVAT). RESULTS: The gene with the strongest simulated effect, MAP4, did not meet the Bonferroni corrected significance threshold. However, analysis of cases and controls using our selection method substantially improved the significance of MAP4, despite the reduction in sample size. CONCLUSIONS: Taking the additional steps to select the optimal cases and controls from large family data sets can help ensure that only informative individuals are included in analysis and may improve the ability to detect rare variants. BioMed Central 2016-10-18 /pmc/articles/PMC5133500/ /pubmed/27980641 http://dx.doi.org/10.1186/s12919-016-0035-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Proceedings
Sippy, Rachel
Kolesar, Jill M
Darst, Burcu F
Engelman, Corinne D
Prioritization of family member sequencing for the detection of rare variants
title Prioritization of family member sequencing for the detection of rare variants
title_full Prioritization of family member sequencing for the detection of rare variants
title_fullStr Prioritization of family member sequencing for the detection of rare variants
title_full_unstemmed Prioritization of family member sequencing for the detection of rare variants
title_short Prioritization of family member sequencing for the detection of rare variants
title_sort prioritization of family member sequencing for the detection of rare variants
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133500/
https://www.ncbi.nlm.nih.gov/pubmed/27980641
http://dx.doi.org/10.1186/s12919-016-0035-8
work_keys_str_mv AT sippyrachel prioritizationoffamilymembersequencingforthedetectionofrarevariants
AT kolesarjillm prioritizationoffamilymembersequencingforthedetectionofrarevariants
AT darstburcuf prioritizationoffamilymembersequencingforthedetectionofrarevariants
AT engelmancorinned prioritizationoffamilymembersequencingforthedetectionofrarevariants